Which risk is associated with intraperitoneal administration of urethane?

Which risk is associated with intraperitoneal administration of urethane?

• A. Allergy
• B. Tumor formation and intestinal irritation
• C. Hypotension
• D. Immediate recovery

Answer: (B)

Urethane is a known carcinogen, so exposing the peritoneal cavity directly to it carries the risk of tumor development and irritation of nearby tissues. When given intraperitoneally, the chemical contacts the peritoneal lining and abdominal organs, increasing the likelihood of neoplastic changes and local inflammation of the intestines. This combination of carcinogenic potential and local irritant effects makes tumor formation and intestinal irritation the primary safety concerns with this route. Allergic reactions or immediate recovery aren’t the typical risks associated with urethane’s intraperitoneal administration.

Urethane is a known carcinogen, so exposing the peritoneal cavity directly to it carries the risk of tumor development and irritation of nearby tissues. When given intraperitoneally, the chemical contacts the peritoneal lining and abdominal organs, increasing the likelihood of neoplastic changes and local inflammation of the intestines. This combination of carcinogenic potential and local irritant effects makes tumor formation and intestinal irritation the primary safety concerns with this route. Allergic reactions or immediate recovery aren’t the typical risks associated with urethane’s intraperitoneal administration.